Hussain Mussarrat, Goldberg David J
Skin Laser & Surgery Specialists of New York & New Jersey, New York, NY, USA.
J Cosmet Laser Ther. 2007 Dec;9(4):232-6. doi: 10.1080/14764170701704668.
This study evaluated the effects of a manganese peptide complex in the treatment of various signs of cutaneous facial photodamage. Individuals used a facial serum formulation containing the manganese peptide complex Manganese Tripeptide-1 twice a day for up to 12 weeks. At the end of the treatment period, the individuals and a blinded investigator noted improvement in the appearance of several signs of cutaneous photodamage. Predominant among the parameters showing improvement were those associated with hyperpigmentation. In general, at the end of 12 weeks of treatment, photodamage ranking moved from moderate to mild. Treatment was well tolerated with no significant cutaneous inflammation induced by the manganese peptide complex.
本研究评估了一种锰肽复合物对治疗面部皮肤光损伤各种体征的效果。受试者每天两次使用含有锰肽复合物三肽-1的面部精华液配方，持续使用长达12周。在治疗期结束时，受试者和一位不知情的研究者均注意到皮肤光损伤的几种体征外观有所改善。在显示出改善的参数中，主要是与色素沉着相关的参数。总体而言，在12周治疗结束时，光损伤等级从中度变为轻度。该治疗耐受性良好，锰肽复合物未引起明显的皮肤炎症。
